Amedex Therapeutics

Lakewood-Amedex is a privately-held, clinical-stage pharmaceutical company developing a series of first-class antibacterial and antifungal therapeutic drugs, known as bisphosphonates. To date, this novel antimicrobial agent has demonstrated rapid bactericidal effects against more than 70 different bacterial strains, including many antibiotic-resistant and biofilm-forming bacteria. Amid the growing crisis of multidrug-resistant infections, Lakewood's clinical development pipeline focuses on addressing the most life-threatening disease indications.